Research Portfolio
We invite you to learn about the Foundation's research grants. The search feature and the table below represent the Foundation's complete research portfolio. You may search the complete list of grants by status (open/active or closed/inactive), research program area, and disease.
If you are interested in a specific research program area, browse the recently funded research by program area.
To browse active grants you may also wish to view the 2020 Grants Portfolio publication.
Filter for Grant pages
Keyword Search for Grant pages
Search Results
|
Title |
Institution |
Investigator |
Status |
Research Program Area |
| 02534: Clinical Trial for Evaluation of Propranolol and Doxorubicin in the Treatment of Canine Hemangiosarcoma | University of Minnesota | Erin B. Dickerson, PhD and Brian Husbands, DVM | Open | Oncology - Hemangiosarcoma |
| 02643-A: Examination of the Effects of Cannabidiol on Canine Neoplastic Cell Apoptosis/Autophagy and Potential for Chemotherapy Resistance or Sensitivity | Cornell University | Joseph J. Wakshlag, DVM, PhD | Open | Oncology |
| 02595-A: Defining the Flow Cytometric Characteristics of Normal and Diseased Canine Spleen and Visceral Lymph Nodes | University of Minnesota | Courtney E. Johnson, DVM | Open | Oncology |
| 02636-A: Development of RNA in-situ Hybridization to Identify T Regulatory Cells and their Function within the Tumor Microenvironment of Canine Oral Malignant Melanoma | University of Florida | Sandra M. Bechtel, DVM | Open | Oncology |
| 02663: Comparative Brain Tumor Consortium (CBTC) Meningioma Pathology Board | National Institutes of Health/National Cancer Institute/Center for Cancer Research/Comparative Oncology Program, Cornell University, and University of Pennsylvania | Amy LeBlanc, DVM, Andrew Miller, DVM and Molly Church, MS, VMD, PhD | Open | Oncology |
| 02642-A: NF-kappaB Inactivation Enhances Apoptosis in Canine Osteosarcoma Cells | University of Georgia | Travis Laver, VMD, PhD | Open | Oncology - Osteosarcoma |
| 02487: OX40 Checkpoint Molecule Targeted Antibodies for Cancer Immunotherapy in Dogs | Colorado State University | Steven W. Dow, DVM, PhD | Open | Oncology |
| 02510-T: Identification of Novel Synthetic Lethal Partners to Optimize PI3K Targeted Therapies in Canine Hemangiosarcoma | Tufts University School of Medicine | Cheryl A. London, DVM, PhD | Open | Oncology - Hemangiosarcoma |
| 2489: Tumor-permissive Collagen Signatures in Canine Mammary Gland Tumors: Development of Prognostic Markers and Targeted Therapies for Improved Outcomes | University of Pennsylvania | Susan W. Volk, VMD, PhD | Open | Oncology |
| 02522-A: The Investigation of Lypoxigenase-5 Expression in Canine Normal, Hyperplastic and Neoplastic Urinary Bladder Epithelium | University of Liverpool | Riccardo Finotello, DVM, PhD | Closed | Oncology |
| 02502: Precision Medicine for Canine Lymphoma | Trustees of the University of Pennsylvania | Nicola J Mason, BVetMed, PhD | Open | Oncology - Lymphoma |
| 02519: Prevalence of Bartonella spp. Infection in Dogs with Cardiac and Splenic Hemangiosarcomas within and between Geographic Locations | North Carolina State University | Edward B Breitschwerdt, DVM; Matthew Breen, PhD | Open | Oncology - Hemangiosarcoma |
| 02500: Immune Targeting of the V600E B-Raf Neoantigen in Canine Urothelial Carcinoma | University of Pennsylvania | Nicola J Mason, BVetMed, PhD | Open | Oncology |
| 02456-A: The Impact of Intravenous Anesthetic Agents on Canine Natural Killer Cell | Trustees of the University of Pennsylvania | Oliver A Garden, BVetMed, PhD | Open | Oncology |
| 02455-A: Identification of genetic mutations in anal sac carcinoma in English Cocker Spaniels | University of Georgia | Shaying Zhao, PhD | Closed | Oncology |
| 02405-A: Transcriptome Based Diagnostics in Canine Soft Tissue Sarcoma | Cornell University | Andrew D. Miller, DVM | Closed | Oncology |
| 02321: Clinical Trial of Procaspase-3 Activator (PAC-1) in Combination with Hydroxyurea for Treatment of Canine Meningioma | University of Illinois | Timothy M. Fan, DVM, PhD | Open | Oncology |
| 02316: Genetic Risk Factors for Canine T zone Lymphoma | Colorado State University | Anne A. Avery, DVM, PhD | Open | Oncology - Lymphoma |
| 02317: The Role of Complex Translocations Associated with TP53 Somatic Mutations for Aiding Prognosis of Canine Diffuse Large B cell Lymphoma | North Carolina State University | Matthew Breen, PhD | Open | Oncology - Lymphoma |
| 2309-T: Targeting the Cancer Epigenome: The Effect of Specific Histone Lysine Methyltransferase Inhibition in Canine B-Cell Lymphoma | University of Missouri | Angela McCleary-Wheeler, DVM, PhD | Open | Oncology - Lymphoma |
| 02318: Genetic and Environmental Risk for Lymphoma in Boxer Dogs | University of Wisconsin, Madison | Lauren A. Trepanier, DVM, PhD | Closed | Oncology - Lymphoma |
| 02304-A: Investigating a Biomarker and Novel Therapeutic Target for Canine Diffuse Large B Cell Lymphoma | North Carolina State University | Jennifer A. Luff, VMD, PhD | Closed | Oncology - Lymphoma |
| 02315-A: Discovering Peptide Targets for Development of Adoptive Cell Therapy for Peripheral T-Cell Lymphoma | North Carolina State University | Paul R. Hess, DVM, PhD | Closed | Oncology - Lymphoma |
| 02234-MOU: A Novel Approach for Prevention of Canine Hemangiosarcoma | University of Minnesota | Jaime F Modiano, VMD, PhD | Open | Oncology - Hemangiosarcoma |
| 02215: A Cancer Vaccine for Canine Osteosarcoma | University of Florida | Rowan J Milner, BVSc | Closed | Oncology, Oncology - Osteosarcoma |
| 02237-A: Capturing Tumor Cells in Canine Blood | Cornell University | Tracy Stokol, PhD | Closed | Oncology |
| 02204-T: Using Enhanced Imaging to Evaluate Tumor Margins for Canine Mammary Cancer and Soft Tissue Sarcoma | Ohio State University | Laura E. Selmic, BVetMed | Closed | Oncology |
| 2217: A Novel Mechanism to Regulate the Growth of Canine Hemangiosarcoma | University of Minnesota | Erin B. Dickerson, PhD | Closed | Oncology, Oncology - Hemangiosarcoma |
| 02171-MOU: Histiocytic Sarcoma in Bernese Mountain Dogs: Novel Approaches To Treatment | Michigan State University | Vilma Yuzbasiyan-Gurkan, PhD | Closed | Oncology |
| 02093-A: Sequencing Histiocytic Sarcoma (HS) loci identified by Genetic Association studies in the Bernese Mountain Dog (BMD) | CNRS - University of Rennes | Catherine Andre, PhD | Closed | Oncology |
| 02091-A: Differentiating between Localized and Disseminated Histiocytic Sarcoma in Bernese Mountain Dogs | National Human Genome Research Institute | Elaine A Ostrander, PhD | Closed | Oncology |
| 01949-A: Targeting the Cell's Activation Machinery to Halt Tumor Metastasis in Canine Osteosarcoma | Oregon State University | Shay Bracha, DVM, MS | Closed | Oncology - Osteosarcoma |
| 02071: Development of a Therapeutic Brain Tumor Vaccine | University of Minnesota | Grace Elizabeth Pluhar, DVM, PhD | Closed | Oncology |
| 01889-G: Innovations in Prevention, Diagnosis, and Treatment of Cancer - Goldens Lead the Way | University of Minnesota | Jaime F Modiano, VMD, PhD | Closed | Oncology |
| 02092-A: Developing the Use of a Novel Imaging Technique to Define a Dog's Potential Responsiveness to Chemotherapy | Purdue University | Michael O. Childress, DVM, MS | Closed | Oncology - Lymphoma |
| 02081-A: Integrating Cutting Edge Science with Scientific Training to Defeat Hemangiosarcoma | University of Minnesota | Jaime F Modiano, VMD, PhD | Closed | Oncology - Hemangiosarcoma |
| 01918-G: Discovery of Biomarkers to Detect Lymphoma Risk, Classify For Treatment, and Predict Outcome in Golden Retrievers | University of Missouri, Columbia | Jeffrey N. Bryan, DVM | Closed | Oncology - Lymphoma |
| 01929-A: Arginine Dependence: Identification of Cancer's Achilles Heel | University of California, Davis | Carlos O. Rodriguez Jr, DVM, PhD | Closed | Oncology |
| 01925-A: Discovery of Novel Micro-Ribonucleic Acids for Diagnosis and Prognosis of Canine Hemangiosarcoma | Auburn University | Bruce F Smith, VMD, PhD | Closed | Oncology - Hemangiosarcoma |
| 1806: A Novel Virus-Based Anti-Tumor Treatment for Canine Osteosarcoma | Auburn University | Bruce F Smith, VMD, PhD | Closed | Oncology - Osteosarcoma |
| 01914-A: Defining the Genes That Contribute to the Development of Soft Tissue Sarcomas | University of Utrecht | Kim Miranda Boerkamp, DVM | Closed | Oncology |
| 01903-A: Defining the Anti-Tumor Activity of Monocytes in Osteosarcoma | North Carolina State University | Duncan Lascelles, PhD | Closed | Oncology - Osteosarcoma |
| 01911-A: Enhanced Hemangiosarcoma Therapy Using a Novel Combination of Drugs That Target Tumor Proliferation | Van Andel Research Institute | Nicholas S. Duesbery, PhD | Closed | Oncology - Hemangiosarcoma |
| 01912-A: Enhancing the Safety and Efficacy of Anti-Cancer Drugs in Dogs | Research Foundation of State University of New York | Javier G. Blanco, PhD | Closed | Oncology |
| 01822: Beyond the Genome: The Intersection of Genes and the Environment in Canine Cancer | University of California, Los Angeles | Robert K Wayne, PhD | Closed | Oncology |
| 01826: A Novel Treatment for Brain Tumors Using a One Medicine Approach | University of Georgia | Simon R. Platt, BVMS | Closed | Oncology |
| 1787: Clinical Advancement of a Cancer Vaccine in Dogs | University of Pennsylvania | Nicola J Mason, BVetMed, PhD | Closed | Oncology - Lymphoma |
| 01759: Disrupting the Differentiation of Cancer Stem Cells to Prevent the Spread of Hemangiosarcoma | University of Minnesota | Jaime F Modiano, VMD, PhD | Closed | Oncology - Hemangiosarcoma |
| 01843: Further Investigation of the Genes Controlling Canine Leukemia to Properly Diagnose and Control the Disease | North Carolina State University | Matthew Breen, PhD | Closed | Oncology |
| 01876-A: Ensuring That Emerging Stem Cell Treatments Do Not Activate or Exacerbate Cancer in Dogs | Colorado State University | Douglas H Thamm, VMD | Closed | Oncology |
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.
